Experience
Dean Linden, Principal of Private Credit Solutions at Cypress Hills, brings over 28 years of expertise in finance and business development. He was instrumental in the $1.7 billion acquisition of ID Biomedical by GlaxoSmithKline in 2005, a transaction noted as the largest biotech deal in Canada for that decade. His adeptness in forming strategic capital alliances is exemplified through his collaboration with Linden Capital, backed by his brother, Trevor Linden, showcasing their shared entrepreneurial legacy.
Key Responsibilities
At Cypress Hills Partners, Dean Linden concentrates on cultivating family offices and high-net-worth investor relationships and providing strategic guidance for the development of the business.